Rare diseases
Investigational molecules
Locations
Carrer De Pere IV 128 3rd Floor, 08005 Barcelona, Spain
Medica Scientia Innovation Research S.L. concentrates much of its clinical research activity on advanced breast cancer, with particular attention to triple-negative breast cancer, hormone receptor-positive disease, HER2-positive disease, and HER2-low and HER2-ultralow subtypes. Its studies also include early-stage breast cancer, metastatic breast cancer, and biologically defined groups such as ESR1-mutated, PIK3CA-mutated, and PTEN-altered tumors.
The portfolio also includes research in metaplastic breast cancer, aggressive disease settings, and breast tumors with distinct molecular features that guide treatment selection.
Medica Scientia Innovation Research S.L. runs clinical trials in conditions such as Hormone receptor positive HER2 negative breast cancer, HER2 positive breast cancer, Triple negative breast cancer, Breast cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
GermanySpainSpainGermanyAustriaAustriaSpainAustria
FranceSpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
